07.Issue 08 august 23 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 10, Issue : 08, August – 2023

Title:

07.A REVIEW ON METHOD DEVELOPMENT AND VALIDATION OF LC-MS/MS FOR ANALYZING POTENTIAL GENOTOXIC IMPURITIES IN GLIFLOZINS
‬

Authors :

B. Akhila*, B.V. Ramana

The objective of this paper is to review the method development, optimize and validation of the method for the potential genotoxic impurities in gliflozins. The purpose of this validation is to show that processes involved in the development and manufacture of drug, production and analytical testing can be performed in an effective and reproducible manner. This review article provides guidance on how to perform validation characteristics for the analytical method which are utilized in pharmaceutical analysis.
Key words: Analytical method development, Genotoxic impurities, Pharmaceutical analysis, Validation

Cite This Article:

Please cite this article in press B. Akhila et al, A Review On Method Development And Validation Of Lc-MS/MS For Analyzing Potential Genotoxic Impurities In Gliflozins, Indo Am. J. P. Sci, 2023; 10 (08).

Number of Downloads : 10

References:

1. Han S, Hagan DL, Taylor JR, et al. Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats. Diabetes. 2008;57:1723–1729.
2. Sistare FD, Morton D, Alden C, et al. An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines. Toxicol Pathol. 2011;39:716–744.
3. Maeshima H, Ohno K, Nakano S, Yamada T. Validation of an in vitro screening test for predicting the tumor promoting potential of chemicals based on gene expression. Toxicol In Vitro. 2010;24:995–1001.
4. US Food and Drug Administration. FDA briefing document for the July 19, 2011 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee. NDA 202293; Dapagliflozin tablets. US Food and Drug Administration. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM262994.pdf (Accessed January 9, 2014).
5. International Conference on Harmonisation of Technical Requirement for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline: guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1). International Conference on Harmonisation Web site. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4/S2R1_Step4.pdf (Accessed July 2, 2013).
6. Obermeier M, Yao M, Khanna A, et al. In vitro characterization and pharmacokinetics of dapagliflozin (BMS-512148), a potent sodium–glucose cotransporter type II inhibitor, in animals and humans. Drug Metab Dispos. 2010;38:405–414.
7. Jeyabaskaran.M, Rambabu.C, Dhanalakshmi.B. RP-HPLC method development and validation of dapagliflozin in bulk and tablet formulation. International journal of pharmaceutical and analytical research. 2013; 2(4):221-226.
8. Sanagapati M, Dhanalakshmi K, Nagarjunareddy G, Sreenivasa S. Development and validation of a RP-HPLC method for the estimation of dapagliflozin in API. International Journal of Pharmaceutical Sciences and Research. 2014; 5(12):5394- 7.
9. Sanagapati M, Dhanalakshmi K, Reddy NG, Sreenivasa S. Method development and validation of Dapagliflozin API by UV spectroscopy. Int J Pharm Sci Rev Res. 2014 Jul;27(1):270-272.
10. Mohammad Yunoos, Gowri sankar D. A validated stability indicating highperformance liquid chromatographic method for simultaneous determination of metformin hcl and dapagliflozin in bulk drug and tablet dosage form. Asian journal of pharmaceutical and clinical research. 2015; 8(3):320-326.
11. Shyamala NB, Kavitha M. Pooja and JVC Sharma Validated RP-HPLC method for Simultaneous estimation of Metformin Hydrochloride and Dapagliflozin in tablet dosage form. American journal of Biological and Pharmaceutical Research. 2015; 2(2):109-13.
12. Aubry AF, Gu H, Magnier R, Morgan L, Xu X, Tirmenstein M, Wang B, Deng Y, Cai J, Couerbe P, Arnold M. Validated LC–MS/MS methods for the determination of dapagliflozin, a sodium-glucose co-transporter 2 inhibitor in normal and ZDF rat plasma. Bioanalysis. 2010 Dec;2(12):2001-9.
13. Karuna PC, China E, Basaveswara Rao MV. Unique UV spectrophotometric method for reckoning of Dapagliflozin in bulk and pharmaceutical dosage forms. J Chem Pharm Res. 2015;7(9):45-9.
14. Sarkar S, Patel VP. Method Development and Validation of Dapagliflozin Drug in Bulk and Tablet Dosage form by RP-HPLC. Int J Pharma Res Health Sci. 2017; 5 (4):1755-59.
15. Manasa S, Dhanalakshmi K, Reddy GN, Sreenivasa S. Method development and validation of dapagliflozin in API by RPHPLC and UV-spectroscopy. Int J Pharm Sci Drug Res. 2014; 6(3):250- 252.
16. Meira RZC, Maciel AB, Murakami FS, Oliveira PR, Bernardi LS. In Vitro Dissolution Profile of Dapagliflozin: Development, Method Validation and analysis of Commercial Tablets. International Journal of Analytical Chemistry. 2017 available from https://doi.org/10.1155/2017/2951529
17. Verma MV, Patel CJ, Patel MM. Development and stability indicating HPLC method for dapaglif lozin in api and pharmaceutical dosage form. Int J Appl Pharm. 2017; 9(5): 33-41.
18. Debata J, Kumar S, Jha SK, Khan A. A New RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet Dosage Form. Int J Drug Dev & Res.2017; 9: 48-51.
19. Jeyabaskaran M, Rambabu C, Dhanalakshmi B. RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Table Formulation. Int. J. of Pharmacy and Analytical Research.2013; 2(4):221-226.
20. Sura S, Modalavalasa RR, Kothapalli CB. Validation of a Newly Developed Stability Indicating RP-Liquid Chromatographic Method for the Quantitative Determination of Dapagliflozin. Der Pharma Chemica. 2018; 10(1): 93-102.
21. Pate CJ, Verma MV, Patel MM. Simultaneous estimation of Dapagliflozin in API and pharmaceutical dosage form by development and stability indicating HPLC method. World Journal of Pharmacy and Pharmaceutical Sciences. 2017; 6(7): 1618-1632.
22. Mohammad Y, Gowri DS. A validated stability indicating HPLC method for simultaneous determination of metformin hydrochloride and dapagliflozin in bulk drug and tablet dosage form. A J Pharm Clin Res.2015; 8:320-326.
23. Shyamala, Nidhi B, Kavita M, Sharma P, Sharma JVC. Validated RP-HPLC method for Simultaneous estimation of Metformin Hydrochloride and Dapagliflozin in tablet dosage form. American journal of Biological and Pharmaceutical Research, 2015; 2(2): 109-113.
24. Afshan Urooj, P Shyam Sundar, R Vasanthi, M Alagar Raja, K Rajeswar Dutt, KNV Rao, H Ramana. Development and Validation of RP-HPLC method for simultaneous estimation of Dapagliflozin and Metformin in bulk and in synthetic mixture. World Journal of Pharmacy and Pharmaceutical sciences. 2017; 6(7): 2139-2150.
25. Patel KJ, Chaudhary AB. Stability Indicating RP-HPLC Method Development and Validation for Estimation of Dapagliflozin and Metformin HCL. World Journal of Pharmacy and Pharmaceutical Sciences.2017; 6(9): 796-809.
26. Kommineni V, Chowdary KPR, Prasad SVUM. Development of a New Stability Indicating RP-HPLC Method for Simultaneous Estimation of Saxagliptin and Dapagliflozin and Its Validation as Per ICH Guidelines. Indo Americal Journal of Pharmaceutical sciences. 2017; 4 (9):2920-2932.
27. Patel AB, Pate DR, Shah Z. Development and Validation of Stability Indicating Method for the Simultaneous Estimation of Saxagliptin Hydrochloride and Dapagliflozin Using RP-HPLC Method in Tablet Dosage Form. World Journal of Pharmacy and Pharmaceutical Sciences. 2017; 6(10): 444-458.
28. Singh N, Bansal P, Maithani M, Chauhana Y. Development and validation of a stability-indicating RP-HPLC method for simultaneous determination of dapagliflozin and saxagliptin in fixed-dose combination. New Journal of chemistry.2018; 42: 2459-2466.
29. Patel A, Maheshwari D. Development and Validation of UV Spectrophotometric Method and RP-HPLC Method for Simultaneous Estimation of Dapagliflozin Propanediol and Glimepiride in Synthetic Mixture. European Journal of Pharmaceutical and Medicinal Research. 2017;4(7): 416-434.
30. Basha SS, Sravanthi P. Development and Validation of Dapagliflozin by Reversed-Phase High-Performance Liquid Chromatography Method and It’s Forced Degradation Studies. Asian J Pharm Clin Res. 2017; 10(11):101-105.
31. Mante GV, Hemke AT and Umekar MJ. RP-HPLC Method for Estimation of Dapagliflozin from its Tablet. International Journal of ChemTech Research. 2018; 11(01): 242-248.
32. Game MD, Bopudi N. Development and Validation of Stability Indicating HPLC Method for Estimation of Dapagliflozin in Marketed Formulation. International Journal of Pharmacy and Pharmaceutical research. 2018; 12 (3): 123-144.
33. Subudhi SK, Bonagani N, Vadicherla S, Merugu M. Stability Indicating RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Pharmaceutical Dosage Form. Indo American Journal of Pharmacy an International Peer Review Journal. 2017;3(6): 321-329
34. Illendula S, Niranjan B , Kumar KP, Rao GK, Rao KNV, Dutt KR. Development and Validation of Stability Indicating Quantitative Estimation of Dapagliflozin in Bulk and Pharmaceutical Dosage Form by RP-HPLC. Indo Americal Journal of Pharm Sci. 2018; 05 (01): 615-620
35. Khalil GA, Ismail S, Mohammed SG, Mohammed AH. Validated RP-HPLC Method For Simultaneous Determination Of Canagliflozin, Dapagliflozin, Empagliflozin And Metformin. IJPCBS.2018; 8(1): 1-13.Deepan T, Rao MVB, Dhanaraju MD. Development of Validated Stability Indicating Assay Method for Simultaneous Estimation of Metformin and Dapagliflozin by RP- HPLC. European Journal of Applied Sciences. 2017; 9 (4): 189-199
36. Prameela KL, Veni PRK, Satyanarayana PVV, Babu BH. Development and Validation of Stability Indicating Reverse Phase High Performance Liquid Chromatography Method with Photodiode Array Detection for The Simultaneous Estimation Of Hypoglycemic Agents Dapagliflozin And Metformin. Int J Pharma Bio Sci .2017; 8(3): 328-336
37. Mante GV, Gupta KR, Hemke AT. Estimation of Dapagliflozin from its Tablet Formulation by UV-Spectrophotometry. Pharm Methods. 2017; 8(2): 102-107.
38. Jani BR, Shah KV, Kapupara PP. Development and validation of UV spectroscopic first derivative method for simultaneous estimation of dapagliflozin and metformin hydrochloride in synthetic mixture. J Bioequiv Stud. 2015; 1(1):102.
39. Sanagapati M, Dhanalakshmi K, Reddy NG, Kavitha B. Method Development and Validation of Dapagliflozin API by UV Spectroscopy. Int J Pharm Sci Rev Res. 2014; 27(1):270-272.
40. Zameeruddin M, Bundel SS, Bharkad VB, Khan HN, Thoke ST. Development and validation of UV spectroscopic method for simultaneous estimation of dapagliflozin and saxagliptin in synthetic mixture. Int. J. of Pharmacy and Analytical Research. 2019; 8(1):59-66.
41. Chit ra K P, Eswaraiah MC, Rao MVB. Unique U V spectrophotometric method for reckoning of Dapagliflozin in bulk and Pharmaceutical Dosage forms. Journal of chemical and Pharmaceutical Research 2015; 7(9):45-49.
42. Madhavi S, Rani AP. Development and Validation of a Method For simultaneous Determination of Dapagliflozin and Saxagliptin in a Formulation by RP-UPLC. WJPR. 2017; 6(12): 904-916.